logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Beacon Therapeutics Appoints Lance Baldo As CEO and Thomas Biancardi As CFO

Jul 24, 2024•over 1 year ago

Position

Chief Executive Officer

Company

Beacon Therapeutics

Lance Baldo
AlachuaTherapeuticsBiotechnologyHealth Care

Description

Beacon Therapeutics Holdings Limited announced the appointment of Lance Baldo, MD as Chief Executive Officer, effective August 12, 2024, and Thomas Biancardi as Chief Financial Officer, effective August 1, 2024, following a $170 million Series B fundraise. The outgoing CEO, Dave Fellows, will assume the role of non-Executive Chairman of the Board in January 2025.

Company Information

Company

Beacon Therapeutics

Location

Alachua, Florida, United States

About

Beacon Therapeutics is a clinical-stage biotechnology company with a mission to save and restore the vision of patients with blinding retinal diseases. The Company has an established scientific foundation that includes a late-stage clinical development candidate to treat XLRP and two preclinical programs targeting dry age-related macular degeneration (AMD) and an inherited cone-rod dystrophy (CRD).

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months